This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 23-26, 2024
Hynes Convention CenterBoston, MA

Dr YeonTae Jeong
Head of Upstream Process Development at Samsung Biologics


YeonTae Jeong is the Head of Upstream Process Development at Samsung Biologics. He has over 15 years of experience in upstream processes in the biopharmaceutical industry, including various roles in MSAT and process development at Samsung Biologics, Amgen and Daewoong Pharmaceutical. YeonTae holds a Ph.D. in Biological Sciences from KAIST in South Korea.

Agenda Sessions

  • Optimizing Charge Variant Profiles of mAbs Through Targeted Media and Additive Screening During Upstream Process Development